Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Intercept Pharmaceuticals, Inc.
About ICPT
Intercept Pharmaceuticals, Inc. is a biopharmaceutical company that is focused on the development and commercialization of therapeutics to treat progressive non-viral liver diseases with unmet medical need utilizing its bile acid chemistry. Its product candidates include Ocaliva (obeticholic (OCA)) for liver fibrosis due to nonalcoholic steatohepatitis (NASH), OCA and Bezafibrate, and Other Product Candidates. The Company’s marketed product, Ocaliva, is a farnesoid X receptor (FXR) agonist for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA or as monotherapy in adults unable to tolerate UDCA. The Company is evaluating tolerability of OCA in combination with bezafibrate in patients with PBC in a Phase II study outside of the United States. Its other compounds are in early stages of research and development pipeline including INT-787 compound, an FXR agonist is in a Phase IIa clinical trial.
Find out what a historical investment in Intercept Pharmaceuticals, Inc. would be worth today using our ICPT stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy ICPT shares in Australia?
Buying ICPT shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Intercept Pharmaceuticals, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ICPT
What is the ticker symbol of Intercept Pharmaceuticals, Inc.?
The ticker symbol for Intercept Pharmaceuticals, Inc. is ICPT.
How much is one share of ICPT?
One share of ICPT is valued at $19.00 as of 21 May 2026.
What is the market capitalisation of Intercept Pharmaceuticals, Inc. ICPT?
As of 21 May 2026 Intercept Pharmaceuticals, Inc. has a market cap of -.
What is the 52-week high for Intercept Pharmaceuticals, Inc. stock?
The Intercept Pharmaceuticals, Inc. 52-week high stock price is $NaN.
What is the 52-week low for Intercept Pharmaceuticals, Inc. stock?
The Intercept Pharmaceuticals, Inc. 52-week low stock price is $NaN.
Can I buy ICPT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ICPT shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ICPT on Stake
- Buy ICPT from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of ICPT from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
ICPT related stocks